MetaCap

Tiziana Life Sciences Insider Trades

NASDAQ: TLSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6206-0.055 (-8.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $1.04M
Sales
0 · $0
Shares bought / sold
1.05M / 0
Net activity
Net buying $1.0 million

Tiziana Life Sciences insider activity

Over the last 12 months, Tiziana Life Sciences insiders reported 8 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $1.0 million and sold $0 worth of stock, for net insider buying of $1.0 million. The most recent filing shows Elrifi Ivor (Chief Executive Officer) reporting a transaction in 1,050,000 shares on Aug 15, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TLSA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TLSA insider transactions

Tiziana Life Sciences insider transactions
DateInsiderTypeSharesValueFiling
Aug 15, 2026Elrifi IvorChief Executive OfficerOption exercise1,050,000—Form 4
Aug 5, 2026Elrifi IvorChief Executive OfficerBuy237,616$237.62KForm 4
Aug 4, 2026Elrifi IvorChief Executive OfficerBuy83,807$81.29KForm 4
Aug 3, 2026Elrifi IvorChief Executive OfficerBuy667,000$667.00KForm 4
Jul 21, 2026CERRONE GABRIELE MDirectorAward42,357$41.93KForm 4
Jul 21, 2026CERRONE GABRIELE MDirectorBuy42,357$41.93KForm 4
Jun 12, 2026CERRONE GABRIELE MDirectorAward15,000$16.65KForm 4
Jun 12, 2026CERRONE GABRIELE MDirectorBuy15,000$16.65KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related